The last two decades have led to increased use of technological solutions in clinical trials and a broader acceptance of such approaches in the industry and by governmental agencies and ethics committees.
This evolution has changed how we conduct trials, how CROs bid and how sponsors improve trial oversight by accessing trial data in real-time.
In this webinar, the featured speakers will focus on:
- The current state of trial technology
- How important is the interconnection of systems
- How CROs are budgeting for their solutions
- How do efficiencies translate to the sponsors
- How can sponsors get a feel for CRO solutions
- How does the future look like
Join this webinar to learn how a fully unified digital ecosystem impacts study stakeholders in their trial management approach and how these novel approaches influence the budgeting of studies.
Patrick McManus, Chief Development Officer, Clinscience
Patrick McManus holds a Master of Science in Clinical Research from the Danube University Krems and a diploma in business administration and computational sciences from the Academy of Public and Business Administration in Munich. Patrick brings more than 15 years of experience in business development. During his career, he gained a solid understanding of all aspects of clinical trials and held several leading positions in the business development area in mid-size CROs.Message Presenter
Leif Kuse, CEO and Founder, Pharall
Leif has a vast amount of business experience in the field of clinical outsourcing since 2004, including vendor management, budgeting and project controlling for biotech companies, CROs and the pharmaceutical industries. He implemented various governance models for big pharma companies and managed various partnerships between pharma companies and CROs. Leif is the former Head of Purchasing at Fresenius Biotech Germany. He also held investment management positions at different venture capital funds after finishing his academic studies in business administration and law.Message Presenter
Robert Dobosz, Director of Clinical Operations, Ryvu Therapeutics
With nearly 20 years in the industry, Robert Dobosz worked for big pharma, small and big CROs, and dynamically developing biotechs. Managing studies from early development and registrational trials until phase IV in various therapeutic areas. In 2013, he shared his knowledge and expertise in clinical studies conducted with Medical University students (Collegium Medicum of Jagiellonian University).Message Presenter
Who Should Attend?
- CEO, Chief Medical Officer (CMO)
- SVP/VP/Sr. Director/Director of
- Clinical Operations
- Clinical Research
- Data Management
- Biometrics or Biostatistics
- Project Manager
- Innovation Manager
- SVP/VP/Sr. Director/Director of
- Writers from Outsourcing, Biotech, Clinical Trials and Pharmaceutical Magazines
What You Will Learn
- Gain deeper insights into trial technology-related aspects
- Learn how clinical programs can benefit from such technologies
- Learn how a fully unified digital ecosystem benefits clinical trial budgeting
Clinscience is a global SMART CRO with hubs across five countries in Europe and the United States; as well as offers a satellite presence in five European countries. Since 2020, Clinscience offers full (end-to-end) CRO services from Protocol Development to Final Study Report. Over 150 Biotech Clients trust Our Brand and we expect many more in the near future.
Our uncomplicated procedures and Data-driven approach harnessed with state-of-the-art technology allow us to be smart and agile in meeting our Clients’ needs. Clinscience is a global CRO company offering smart CRO Services, from protocol creation to final study report development. The Company has offices in Poland, Spain, Italy, Germany, US, and India and has a satellite presence in additional 6 European countries. More than 150 Biotechnology companies across Europe and the US trust the Clinscience brand. Clinscience specializes in Oncology, Hemato-Oncology, Cardiovascular Diseases, and Neurology. It has managed more than 500 studies and recruited over 157,352 patients across 3,974 sites globally. The Company’s procedures and Data-driven approach, harnessed with the Genius Suite™ technology, work together to give the Clients power and flexibility to address even the most unique needs. Clinscience is part of a publicly-traded parent company, Neuca Plc, an organization in the pharmaceutical wholesaling and healthcare industry that provides the structure to meet the needs of commercial and non-commercial studies. Visit www.clinscience.com for more information.